These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2974704)

  • 1. Serum IgG brain reactive antibodies in Alzheimer disease and Down syndrome.
    Kumar M; Cohen D; Eisdorfer C
    Alzheimer Dis Assoc Disord; 1988; 2(1):50-5. PubMed ID: 2974704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.
    Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
    J Neurosci; 1989 Aug; 9(8):2710-7. PubMed ID: 2475591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
    Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
    Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases.
    Toh BH; Gibbs CJ; Gajdusek DC; Goudsmit J; Dahl D
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3485-9. PubMed ID: 2582415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
    Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
    Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease.
    Bajo M; Yoo BC; Cairns N; Gratzer M; Lubec G
    Amino Acids; 2001; 21(3):293-301. PubMed ID: 11764410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.
    Singh VK; Fudenberg HH
    Autoimmunity; 1989; 3(2):95-101. PubMed ID: 2535254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from chimpanzees with kuru or Creutzfeldt-Jakob disease; a 62-kDa neurofilament-associated protein reacts with sera from sheep with natural scrapie.
    Toh BH; Gibbs CJ; Gajdusek DC; Tuthill DD; Dahl D
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3894-6. PubMed ID: 3923483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and Down's syndrome antibodies bind to the heavy neurofilament protein of cholinergic neurons.
    Tchernakov K; Soussan L; Hassin-Baer S; Wertman E; Michaelson DM
    Res Immunol; 1992; 143(6):670-5. PubMed ID: 1455060
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease.
    Engidawork E; Gulesserian T; Balic N; Cairns N; Lubec G
    J Neural Transm Suppl; 2001; (61):211-22. PubMed ID: 11771745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G subclasses in older persons with Down syndrome.
    Mehta PD; Dalton AJ; Mehta SP; Percy ME; Sersen EA; Wisniewski HM
    J Neurol Sci; 1993 Jul; 117(1-2):186-91. PubMed ID: 8410055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-binding antibodies in Alzheimer's disease and Down's syndrome.
    Franceschi M; Comola M; Nemni R; Pinto P; Iannaccone S; Smirne S; Canal N
    J Gerontol; 1989 Jul; 44(4):M128-30. PubMed ID: 2525583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
    Bancher C; Lassmann H; Budka H; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM
    Acta Neuropathol; 1987; 74(1):39-46. PubMed ID: 2444063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions.
    Perry G; Friedman R; Kang DH; Manetto V; Autilio-Gambetti L; Gambetti P
    Brain Res; 1987 Sep; 420(2):233-42. PubMed ID: 3676758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.
    Lemere CA; Munger JS; Shi GP; Natkin L; Haass C; Chapman HA; Selkoe DJ
    Am J Pathol; 1995 Apr; 146(4):848-60. PubMed ID: 7717452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer paired helical filaments: cross-reacting polypeptide/s normally present in brain.
    Grundke-Iqbal I; Iqbal K; Tung YC; Wang GP; Wisniewski HM
    Acta Neuropathol; 1985; 66(1):52-61. PubMed ID: 2581415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between two restriction fragment length polymorphisms in the genes for the light and heavy neurofilament proteins and Alzheimer's disease.
    Lacoste-Royal G; Mathieu M; Nalbantoglu J; Julien JP; Gauthier S; Gauvreau D
    Can J Neurol Sci; 1990 Aug; 17(3):302-5. PubMed ID: 1976427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.